The interplay of prostatic inflammation with NF‐κB and GDF‐15 expression in early prostate cancer development is unclear from our study results, although our findings suggest GDF‐15 may repress chronic inflammation in the benign prostate. Here, GDF15 is linked to prostate carcinoma.